SR-8278 is an experimental drug that was developed as an antagonist of Rev-ErbAñ. It has been used to demonstrate potential applications of Rev-ErbAñ antagonists in the treatment of conditions such as Duchenne muscular dystrophy and Alzheimer's disease.